ORCID as entered in ROS

Select Publications
2018, 'Cooperativity of HOXA5 and STAT3 Is Critical for HDAC8 Inhibition-Mediated Transcriptional Activation of PD-L1 in Human Melanoma Cells', Journal of Investigative Dermatology, 138, pp. 922 - 932, http://dx.doi.org/10.1016/j.jid.2017.11.009
,2018, 'Delineation of the frequency and boundary of chromosomal copy number variations in paediatric neuroblastoma', Cell Cycle, 17, pp. 749 - 758, http://dx.doi.org/10.1080/15384101.2017.1421875
,2018, 'The histone chaperone complex FACT promotes proliferative switch of G
2017, 'Up-regulation of LYAR blocks Myc-induced cell death', Cell Cycle, 16, pp. 1857 - 1858, http://dx.doi.org/10.1080/15384101.2017.1374682
,2017, 'PD-L1 is a therapeutic target of the bromodomain inhibitor JQ1 and, combined with HLA class I, a promising prognostic biomarker in neuroblastoma', Clinical Cancer Research, 23, pp. 4462 - 4472, http://dx.doi.org/10.1158/1078-0432.CCR-16-2601
,2017, 'The histone methyltransferase DOT1L promotes neuroblastoma by regulating gene transcription', Cancer Research, 77, pp. 2522 - 2533, http://dx.doi.org/10.1158/0008-5472.CAN-16-1663
,2017, 'The regulatory role of long noncoding RNAs in cancer', Cancer Letters, 391, pp. 12 - 19, http://dx.doi.org/10.1016/j.canlet.2017.01.010
,2017, 'A Myc activity signature predicts poor clinical outcomes in Myc-associated cancers', Cancer Research, 77, pp. 971 - 981, http://dx.doi.org/10.1158/0008-5472.CAN-15-2906
,2017, 'Chromosome preference of disease genes and vectorization for the prediction of non-coding disease genes', Oncotarget, 8, pp. 78901 - 78916, http://dx.doi.org/10.18632/oncotarget.20481
,2017, 'Upregulation of LYAR induces neuroblastoma cell proliferation and survival', Cell Death and Differentiation, 24, pp. 1645 - 1654, http://dx.doi.org/10.1038/cdd.2017.98
,2017, 'PDK1 promotes tumor cell proliferation and migration by enhancing the Warburg effect in non-small cell lung cancer', ONCOLOGY REPORTS, 37, pp. 193 - 200, http://dx.doi.org/10.3892/or.2016.5253
,2017, 'Perceptions of Hospital-Dependent Patients on Their Needs for Hospitalization', JOURNAL OF HOSPITAL MEDICINE, 12, pp. 450 - 453, http://dx.doi.org/10.12788/jhm.2756
,2017, 'Prevalence of comorbidities in chronic obstructive pulmonary disease patients A meta-analysis', MEDICINE, 96, http://dx.doi.org/10.1097/MD.0000000000006836
,2016, 'NCYM is upregulated by lncUSMycN and modulates N-Myc expression', International Journal of Oncology, 49, pp. 2464 - 2470, http://dx.doi.org/10.3892/ijo.2016.3730
,2016, 'Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia', Leukemia, 30, pp. 1745 - 1748, http://dx.doi.org/10.1038/leu.2016.24
,2016, 'INPP4B is an oncogenic regulator in human colon cancer', Oncogene, 35, pp. 3049 - 3061, http://dx.doi.org/10.1038/onc.2015.361
,2016, 'Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation', Cell Death and Disease, 7, pp. e2252 - e2252, http://dx.doi.org/10.1038/cddis.2016.123
,2016, 'The bromodomain inhibitor jq1 and the histone deacetylase inhibitor panobinostat synergistically reduce n-myc expression and induce anticancer effects', Clinical Cancer Research, 22, pp. 2534 - 2544, http://dx.doi.org/10.1158/1078-0432.CCR-15-1666
,2016, 'High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients', Cancer Letters, 374, pp. 315 - 323, http://dx.doi.org/10.1016/j.canlet.2016.02.021
,2016, 'MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4', Oncotarget, 7, pp. 54937 - 54951, http://dx.doi.org/10.18632/oncotarget.10709
,2016, 'The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs', Oncotarget, 7, pp. 79217 - 79232, http://dx.doi.org/10.18632/oncotarget.12640
,2016, 'The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression', Oncotarget, 7, pp. 8663 - 8675, http://dx.doi.org/10.18632/oncotarget.6675
,2015, 'WDR5 supports an N-myc transcriptional complex that drives a protumorigenic gene expression signature in neuroblastoma', Cancer Research, 75, pp. 5143 - 5154, http://dx.doi.org/10.1158/0008-5472.CAN-15-0423
,2015, 'Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma', Science Translational Medicine, 7, pp. 312ra176, http://dx.doi.org/10.1126/scitranslmed.aab1803
,2015, 'Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma', Molecular Oncology, 9, pp. 1484 - 1500, http://dx.doi.org/10.1016/j.molonc.2015.04.005
,2015, 'IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma', Journal of Clinical Oncology, 33, pp. 1285 - 1293, http://dx.doi.org/10.1200/JCO.2014.55.9880
,2015, 'Connecting rules from paired miRNA and mRNA expression data sets of HCV patients to detect both inverse and positive regulatory relationships', BMC Genomics, 16, pp. s11, http://dx.doi.org/10.1186/1471-2164-16-S2-S11
,2015, 'Erratum: Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression (Journal of the National Cancer Institute (2014) 106:7 (dju113) DOI: 10.1093/jnci/dju113)', Journal of the National Cancer Institute, 107, http://dx.doi.org/10.1093/jnci/dju359
,2015, 'INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas', Oncotarget, 6, pp. 39891 - 39907, http://dx.doi.org/10.18632/oncotarget.5359
,2015, 'Population testing for cancer predisposing BRCA1/BRCA2 mutations in the ashkenazi-jewish community: A randomized controlled trial', Journal of the National Cancer Institute, 107, http://dx.doi.org/10.1093/jnci/dju379
,2015, 'The histone methyltransferase DOT1L: Regulatory functions and a cancer therapy target', American Journal of Cancer Research, 5, pp. 2823 - 2837
,2015, 'Metadherin is required for the proliferation, migration, and invasion of esophageal squamous cell carcinoma and its meta-analysis', TRANSLATIONAL RESEARCH, 166, pp. 614 - 626, http://dx.doi.org/10.1016/j.trsl.2015.05.004
,2014, 'Effects of a Novel Long Noncoding RNA, lncUSMycN, on N-Myc Expression and Neuroblastoma Progression', Journal of the National Cancer Institute, 106, pp. dju113, http://dx.doi.org/10.1093/jnci/dju113
,2014, 'The novel long noncoding RNA linc00467 promotes cell survival but is down-regulated by N-Myc', Plos One, 9, pp. e88112, http://dx.doi.org/10.1371/journal.pone.0088112
,2014, 'The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1', Oncotarget, 5, pp. 1793 - 1804, http://dx.doi.org/10.18632/oncotarget.1785
,2014, 'Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach', Journal of Proteomics, 96, pp. 1 - 12, http://dx.doi.org/10.1016/j.jprot.2013.10.032
,2014, 'Histone Deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1', Oncotarget, 5, pp. 4257 - 4268, http://dx.doi.org/10.18632/oncotarget.1991
,2014, 'Histone demethylase JARID1B promotes cell proliferation but is downregulated by N-Myc oncoprotein', Oncology Reports, 31, pp. 1935 - 1939, http://dx.doi.org/10.3892/or.2014.3006
,2014, 'Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A2a via AKT in prostate cancer cells', Oncotarget, 5, pp. 6289 - 6299, http://dx.doi.org/10.18632/oncotarget.2198
,2014, 'The prenatal origins of cancer', Nature Reviews Cancer, 14, pp. 277 - 289, http://dx.doi.org/10.1038/nrc3679
,2014, 'TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells', Oncotarget, 5, pp. 10127 - 10139, http://dx.doi.org/10.18632/oncotarget.2466
,2013, 'Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3', Cell Death and Disease, 4, pp. e655 - e655, http://dx.doi.org/10.1038/cddis.2013.192
,2013, 'Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation', Oncogene, 32, pp. 3616 - 3626, http://dx.doi.org/10.1038/onc.2012.368
,2013, 'FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation', Leukemia, 27, pp. 1053 - 1062, http://dx.doi.org/10.1038/leu.2012.361
,2013, 'Histone deacetylase 5 blocks neuroblastoma cell differentiation by interacting with N-Myc', Oncogene, 33, pp. 2987 - 2994, http://dx.doi.org/10.1038/onc.2013.253
,2013, 'PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma', Nature communications, 4, pp. Article number 1508, http://dx.doi.org/10.1038/ncomms2489
,2013, 'Sirtuin-1 regulates acinar to ductal metaplasia and supports cancer cell viability in pancreatic cancer', Cancer research, 73, pp. 2357 - 2367, http://dx.doi.org/10.1158/0008-5472.CAN-12-3359
,2013, 'The histone deacetylase SIRT2 stabilizes Myc oncoproteins', Cell Death and Differentiation, 20, pp. 503 - 514, http://dx.doi.org/10.1038/cdd.2012.147
,2013, 'Tumor protein 53-induced nuclear protein 1 enhances p53 function and represses tumorigenesis', Frontiers in Genetics, 13, pp. Art. No. 80, http://dx.doi.org/10.3389/fgene.2013.00080
,2013, 'Up-regulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16(INK4a) protein and confers resistance to oxidative stress', The Journal of Biological Chemistry, 288, pp. 12032 - 12041, http://dx.doi.org/10.1074/jbc.M112.447821
,